Mobile Trading

AMRUTANJAN HEALTH CARE LTD.

NSE : AMRUTANJANBSE : 590006ISIN CODE : INE098F01031Industry : Pharmaceuticals & DrugsHouse : Amrutanjan
BSE660.0526.95 (+4.26 %)
PREV CLOSE ( ) 633.10
OPEN PRICE ( ) 633.10
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 224
TODAY'S LOW / HIGH ( )629.90 670.00
52 WK LOW / HIGH ( )548.05 829
Select year
ParticularsMar2016Mar2015Mar2014Mar2013Mar2012
Operational & Financial Ratios
   Earnings Per Share (Rs)14.0810.208.516.9232.96
   CEPS(Rs)8.186.205.494.744.51
   DPS(Rs)3.853.503.203.0015.00
   Book NAV/Share(Rs)74.4064.9761.0656.29264.34
   Tax Rate(%)37.0538.2835.7934.6238.98
Margin Ratios
   Core EBITDA Margin(%)15.7213.4814.0512.0012.21
   EBIT Margin(%)16.9214.2114.2112.3812.67
   Pre Tax Margin(%)16.6913.8113.0310.6710.58
   PAT Margin (%)10.518.528.366.976.46
   Cash Profit Margin (%)12.2210.3610.789.548.83
Performance Ratios
   ROA(%)15.5712.2110.188.156.86
   ROE(%)20.2016.1814.5112.6810.79
   ROCE(%)31.7425.5421.7318.2816.36
   Asset Turnover(x)1.481.431.221.171.06
   Sales/Fixed Asset(x)4.404.003.173.142.72
   Working Capital/Sales(x)2.703.072.925.716.22
Efficiency Ratios
   Fixed Capital/Sales(x)0.230.250.320.320.37
   Receivable days51.4854.9065.2957.7436.10
   Inventory Days16.3918.0923.2629.4428.71
   Payable days46.2842.4550.2258.0548.66
Valuation Parameters
   PER(x)14.8223.467.378.382.33
   PCE(x)25.4938.6011.4312.2517.00
   Price/Book(x)5.617.362.062.062.90
   Yield(%)0.920.732.552.591.96
   EV/Net Sales(x)3.023.991.101.231.61
   EV/Core EBITDA(x)15.4723.656.317.8310.12
   EV/EBIT(x)17.0326.707.399.4612.20
   EV/CE(x)4.025.361.301.371.86
   M Cap / Sales3.274.201.291.231.57
Growth Ratio
   Net Sales Growth(%)12.1117.532.97-3.8435.80
   Core EBITDA Growth(%)29.9113.4314.15-4.8926.78
   EBIT Growth(%)33.2317.5617.79-5.0918.62
   PAT Growth(%)38.0619.7723.005.00-5.65
   EPS Growth(%)38.0619.7723.00-79.00-2.20
Financial Stability Ratios
   Total Debt/Equity(x)0.020.030.090.180.28
   Current Ratio(x)3.593.202.871.671.66
   Quick Ratio(x)3.272.872.551.401.30
   Interest Cover(x)75.8134.9611.977.246.05
   Total Debt/Mcap(x)0.000.000.040.090.10

Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020.

Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge.

Pay 20% upfront margin of the transaction value to trade in cash market segment.

Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard.

Check your Securities /MF/ Bonds in the consolidated account statement issued by NSDL/CDSL every month.
.......... Issued in the interest of Investors

INVESTOR CHARTER
© 2018 Ratnakar Securities Pvt. Ltd. All rights reserved.
Designed, Developed & Content Powered by  Accord Fintech Pvt. Ltd.
CLOSE X

Filing complaints on SCORES Easy & quick

  • > Register on SCORES portal (link:https://scores.gov.in)
  • > Mandatory details for filing complaints on SCORES
    • Name
    • PAN
    • Address
    • Mobile Number
    • E-mail ID
  • > Benefits:
    • Effective communication
    • Speedy redressal of the grievances
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.